- Paras Healthcare has ensured unhindered treatment with highest care to cancer patients being treated at its hospitals during the COVID 19 pandemic
- Cancer patients are at risk of severe complications from COVID-19 due to low immunity
- India already has a high cancer death rate because of delayed diagnosis and inequitable access to healthcare
- Healthcare providers must stay committed to providing cancer patients with highest standards of care
New Delhi, August 12, 2020: As world grapples with the COVID 19 pandemic, cancer patients as well as cancer survivors are facing particularly unique challenges, with higher risk of complications from the viral disease, the need to manage their illness and mental health challenges affecting them disproportionately, say experts at leading healthcare provider Paras Healthcare.
With the disease as well as the treatment compromising the immunity of cancer patients and survivors, they face heightened risk of a series of infections, COVID 19 being one of them. Evidence clearly suggests a higher rate of mortality from COVID 19 among people with cancer.
“Cancer patients and survivors are already dealing with a lot of difficulties. The COVID 19 crisis has only made it more challenging for them to manage their illness. Cancer patients and survivors are often immuno-compromised because of the disease or its treatment. A very critical element of disease management in them therefore is the need to safeguard them from all sorts of infections. People with compromised immune systems are not just at higher risk of contracting infections including COVID-19 but are also prone to severe complications from them. This translates into the need for additional precautions and care. Healthcare providers must adopt a comprehensive approach to treatment of cancer patients during these times including ensuring the continuation of highest standards of care, unhindered treatment as well as psychological support,” said Dr Dharminder Nagar, Managing Director, Paras Healthcare.
Cancer patients and their healthcare providers are facing a series of challenges during these times. Patients are worried about how to navigate their daily care, whether it is safe to continue visiting hospitals for chemotherapy or other sessions. They are also concerned about being de-prioritized as care receivers in the ‘new normal’. For patients whose treating hospitals have been converted into COVID 19 centres, there is a sudden crisis of how to continue receiving treatments.
“As cancer care providers, we have also grappled with several questions. For example, the pros and cons of starting or continuing chemotherapy at such a time because chemotherapy suppresses the immune system and makes patients more vulnerable to infections. On the other hand, stopping or delaying treatment puts cancer patients at greater risk of disease progression. Till now we have tried to ensure that no treatments are delayed or stopped. It is also extremely important to completely isolate the wards for cancer patients so that the risk of infection is minimized. At Paras Healthcare, we have been highly considerate of the needs of cancer patients and survivors. We have initiated special measures to ensure that they continue receiving highest standards of care while mitigating risk of infection during treatment, diagnosis as well as imaging,” said Dr R Ranga Rao, Chairman, Paras Cancer Centre, Paras Hospitals, Gurugram.
An often overlooked aspect of cancer treatment is mental health management. Mental health of cancer patients takes a major hit even in normal circumstances. However, currently with a precarious disease situation, they are finding it extremely difficult to cope with the anxiousness and heightened risk of infection.
“We clearly see a rise in incidence of anxiety and depression among cancer patients in the current circumstances. Offering psychological support, counseling and medication support if needed to deal with mental health deterioration is important in these circumstances,” adds Dr Rao.
Two studies published recently in The Lancet journal indicate a high rate of mortality among COVID-19 patients who also have cancer. In one of the studies, data from more than 900 COVID-19 and cancer patients from the US, Canada, and Spain showed a 13% mortality rate. Another study of 800 UK patients with COVID-19 and cancer found a 28% mortality. The studies also concluded that male patients with other COVID-19 mortality risk factors, such as older age and additional co morbidities, had an increased risk of death. However, cancer treatments such as chemotherapy did not appear to have an effect on mortality in either study.
Another study conducted in the US found that 10.4% of 1018 patients with cancer and COVID-19 had died between March and April. As compared to this, the mortality rate was 5.8% for each 100 confirmed cases.
Corporate Comm India(CCI Newswire)
